Showing 20 of 200 recruiting trials for “large-granular-lymphocyte-leukemia”
RecruitingNCT06151730 ↗
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Loncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
CLL-IMPACT: A Clinical Nutrition Trial Investigating Immune and Metabolic Changes in Early-Stage CLL
👨⚕️ Maike Buchner-Mayr, PD Dr., Technisch Universität München📍 1 site📅 Started Jan 2024View details ↗
Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
Allogeneic CARCIK-CD19 in Adults/Pediatric B-cell NHL or Chronic Lymphocytic Leukemia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
RecruitingNCT06125795 ↗
A Study to Assess Change in Functioning and Health Related Quality of Life in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Treatments in Routine Clinical Practice in Spain
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
Universal 4SCAR7U Targeting CD7-positive Malignancies
RecruitingNCT05809284 ↗
Determining the Mechanisms of Loss of CAR T Cell Persistence
👨⚕️ Persis Amrolia, BSc,MBBS,PhD, UCL Institute of Child Health📍 3 sites📅 Started Oct 2023View details ↗
A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLL
Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A Vaccine Booster (GEO-CM04S1) for the Prevention of COVID-19 in Patients With Chronic Lymphocytic Leukemia
Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome
👨⚕️ Jennifer A Woyach, MD, Ohio State University Comprehensive Cancer Center📍 3 sites📅 Started Jul 2023View details ↗
Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT
👨⚕️ Nicola Goekbuget, MD, Department of Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany📍 85 sites📅 Started Jul 2023View details ↗
RecruitingNCT06203652 ↗
The Pathogenesis and Prognostic Factors of Lymphoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →